Pharmaceutical Microbiology
21 January 2015 - 22 January 2015
Pharmaceutical microbiology is of crucial importance to the development and manufacture of pharmaceutical drugs, biologics and devices. Set to take place on the 21st and 22nd January 2015, the event will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods and the latest technology
Join us as we explore key issues in data review and analysis, contamination control strategies, strategies for low endotoxin recovery and best practice in sterile and non-sterile manufacture. Hear presentations from the heart of industry, addressing real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms. Share the wisdom of respected consultants and get the regulators perspective on recent changes and issues under review.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/pharmaceutical-microbiology
Social Media in the Pharma Industry
21 January 2015 - 22 January 2015
As the pharmaceutical industry is advancing, more and more companies are now taking to various mediums like mobile applications, internet and blogs to be socially visible. These channels help them to reach a wider mass and thereby interact not only with like-minded people, but also consumers.
This year's Conference will deliberate on topics like regulatory insights, consumer focussed approach, mobile & website advances, vision for 2015 to name but a few.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/social-media-in-the-pharmaceutical-industry
High Content Analysis & Phenotypic Screening
26 January 2015 - 27 January 2015
The Twelfth Annual High-Content Analysis 2015 meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, high-content screening of 3D models and ultra high-resolution imaging. This year, we will also co-locate CHI’s Inaugural Phenotypic Screening meeting, offering two tracks to choose from, expanded exhibit hall and an offering of user group meetings and dinner courses. The Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically-relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma.
Hilton San Diego Resort & Spa, San Diego, CA, USA
http://www.highcontentanalysis.com/
7th Immunotherapeutics & Immunomonitoring Conference
29 January 2015 - 30 January 2015
Leading experts from the scientific and clinical arenas and industry will present about novel findings and developments in the constantly changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy, as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.
Paradise Point Resort & Spa, San Diego, CA, USA
https://www.gtcbio.com/conferences/immunotherapeutics-immunomonitoring-overview
Novel Immunotherapeutics Summit
29 January 2015 - 30 January 2015
The Summit will begin with a plenary keynote session, and then break into four concurrent conferences, all of which will talk about complementary areas of the latest breakthroughs in the immunology field:
13th Cytokines & Inflammation
This meeting provides a forum for researchers to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, and cytokines signaling pathways.
7th Immunotherapeutics & Immunomonitoring
Leading experts will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment.
3rd Immunogenicity and Immunotoxicity
Delegates will learn about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins.
2nd Innate Immunity
Come learn about discoveries in toll like receptors, inflammasome reactions, the role of the microbiome and non-pathogenic bacteria, and many more.
Paradise Point Resort & Spa, San Diego, CA 92109, USA
https://www.gtcbio.com/conferences/immunotherapeutics-summit-overview?utm_source=nis&utm_medium=EventListing&utm_campaign=nis
13th Cytokines & Inflammation
29 January 2015 - 30 January 2015
Some focused topics we will discuss this meeting include developments in the therapeutic application of cytokines and proposal of new targets, the complex relationship between the immune system and microbes in the homeostasis of mucosal tissues, new findings in the biology and regulation of IL-23 and IL-17, novel means to modulate immune pathways to promote anti-tumor activity, and many more.
Paradise Point Resort & Spa, San Diego, CA, USA
https://www.gtcbio.com/conferences/cytokines-inflammation-overview
Biotherapeutics - Innovative Future Medicine
08 October 2015
In the last decades, biotherapeutics have become a valuable and integral part of modern medicine to treat severe diseases such as cancer, diabetes and rheumatoid arthritis. The first use of biotechnological methods was for the production of insulin. Since then many biotherapeutic medicines have been developed for the treatment of severe diseases such as cancer and many autoimmune diseases and multiple rare diseases. Biotherapeutics are especially attractive due to their highly targeted and specific nature and their relatively low safety risk.
This one day meeting will focus on the recent progress made in the fast moving field of biotherapeutics. Experts from academia and industry will highlight the latest development in this exciting area of research.
National Heart and Lung Institute, Dovehouse Street London SW3 6LY
http://www.smr.org.uk/smr/Meetings/20151008/Default.asp
War on Cancer 2015
20 October 2015
War on Cancer 2015 will bring together the most influential leaders in oncology from around Europe to explore and shape the dialogue on cancer. Join pharmaceutical, health care, scientific and government specialists on October 20th 2015 to discuss the leading initiatives in policy and financing, innovation in prevention, treatment and diagnosis and new methods of community engagement.
THE HAC Armoury House City Road London EC1Y 2BQ
http://www.waroncancer.economist.com
APS Stimulating antimicrobial innovation
22 October 2015
Background to the Meeting:
The pipeline of new antimicrobial agents is critically stagnant with most major pharma players having limited activity in the antibiotics arena over the past three decades. This meeting aims to capture the cutting edge of the antimicrobial innovation in the UK, to understand the barriers to antibiotic discovery, examine innovation ‘hotspots’ in the UK and highlight developments in the current funding landscape for antibiotics discovery and innovation.
The purpose and aims of the APSGB Microbiology and Anti-Infectives Focus Group is to provide a forum for the discussion of all aspects of microbiology and anti-infectives research and development in the pharmaceutical industry and academia, to underpin the importance of microbiology to the pharmaceutical sciences and innovation, and to provide continuing education, resources and a voice for pharmaceutical scientists in the challenging area of antimicrobials development.
National Heart and Lung Institute, Dovehouse Street London SW3 6LY
https://www.apsgb.co.uk/Events/20151022/
Biotech and Money New York 2015
17 November 2015
Biotech and Money New York aims to provide genuine peer 2 peer knowledge sharing, networking and deal making opportunities between CxO level executives, and uncover new ideas to move the industry forward. At its heart is a mission to promote NYC and the region as a center for life science excellence and help build linkages and business opportunities between East Coast life science companies and capital.
The congress is a catalyst for dialogue, debate and deal making to help lead growth in life science and healthcare investment and the building of billion dollar businesses. The congress will help forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in in the industry.
The congress will help promote NYC as a center for life sciences, and provide a physical platform and forum for advancing translation and connecting innovative life science companies with capital and partnership opportunities.
TKP New York Conference Center, New York, USA
http://bit.ly/1ICvzWs
Trends in Medicinal Chemistry
03 December 2015
Sir Simon Campbell CBE FRS, UK
“Science, Art and Drug Discovery - A Personal Perspective”
Dr Magnus Walter, Lilly, UK
“Changing Times and Changing Paradigms in Drug Discovery – a Lilly Perspective”
Dr Chris Selway, Cyclofluidics, UK
“Applications of Flow Chemistry Technology in Drug Discovery and Development”
Dr Mike Hann, GSK, UK
“Moving beyond Molecular Obesity and Potency as addictions in Drug Discovery”
Dr. Gary Tresadern, Janssen, Belgium
“Application of drugability indices within Janssen”
Dr. Yen Choo, Progenitor Therapeutics, UK (TBC)
“Regulation of stem cells with small molecules“
Prof. Stephan Sieber, Munich, Germany
“Natural products and their cellular targets”
National Heart and Lung Institute, Dovehouse Street London SW3 6LY
http://www.smr.org.uk/